Hemispherx brings in Armada to boost US sales, and seeks European partners
This article was originally published in Scrip
Executive Summary
Hemispherx Biopharma has signed an agreement with the specialty pharmacy Armada Health Care to boost sales channels for its natural interferon, Alferon N Injection (interferon alfa-n3, human leukocyte derived), in the US. Hemispherx, based in Philadelphia, Pennsylvania, is also seeking partners for the product in Europe, Latin America and Asia.